Translational PK/PD Modeling for Oncology - Focus on Targeted Protein Degradation

Explore a 17-minute conference talk on translational pharmacokinetic/pharmacodynamic (PK/PD) modeling in oncology, with a specific focus on targeted protein degradation. Delivered by Colin Phipps from AbbVie Inc. on September 23, 2024, this presentation is part of the Frontiers in Computational and Mathematical Medicine series and the Thematic Program on Mathematical Oncology at the Fields Institute. Gain insights into the application of mathematical modeling techniques in cancer research and drug development, particularly in the emerging field of targeted protein degradation. Learn how PK/PD modeling contributes to the advancement of oncology treatments and the optimization of drug efficacy.